welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Tucson drug startup launches gastric-cancer trial
Tucson-based drug startup Cancer Prevention Pharmaceuticals Inc. has announced the launch of a Phase 2 clinical trial at Vanderbilt University Medical Center to test the company’s flagship drug candidate for preventing gastric cancer.
The drug, CPP-1X, will be studied in patients with precancerous gastric lesions who are at high risk for gastric cancer, the company said Monday.
The trial is funded by the National Cancer Institute and run in collaboration with gastroenterologists Dr. Keith T. Wilson and Dr. Douglas R. Morgan of the Vanderbilt University School of Medicine and the Vanderbilt-Ingram Cancer Center.
expertly curated content related to this topic
-
Role of Surgery in Familial Adenomatous Polyposis and Hereditary Non Polyposis Colorectal Cancer (Lynch Syndrome)Surgery remains the mainstay of treatmen...
-
Intestinal Polyps and Polyposis: State-of-the-Art, Multidisciplinary Publication on Polyps and PolyposisNowadays, we are dealing more frequently...
-
Endoscopic Submucosal Dissection to Treat Ileal High-Grade Dysplasia After Ileoanal Anastomosis for Familial Adenoma...Restorative proctocolectomy has become t...
-
Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Survei...The primary objective of this chart revi...
-
The Evolution of Prophylactic Colorectal Surgery for Familial Adenomatous PolyposisINTRODUCTION : Over the past 50 years, p...
-
Victoria’s OTHER Secret: Designer Creates World’s first Lingerie Colostomy Bags as They often Put Partners OffA young designer has taken fashion into ...
-
Colorectal Cancer Chemoprevention: Is This the Future of Colorectal Cancer Prevention?Colorectal cancer (CRC) is presently one...